Cardioneuroablation: a new treatment for vasovagal syncope
- PMID: 39976065
- DOI: 10.2459/JCM.0000000000001703
Cardioneuroablation: a new treatment for vasovagal syncope
Abstract
Cardioneuroablation (CNA) is emerging as an appealing therapeutic option for patients with vasovagal reflex syncope. This review examines key aspects of CNA, including patient selection, procedural aspects and mid-term effects. We critically evaluate procedural results from recent studies and address ongoing challenges, such as the need for standardized procedural protocols and harmonized postprocedural data collection. In addition, we outline current gaps in knowledge concerning long-term pathophysiological effects of the procedure, in particular regarding ventricular arrhythmia susceptibility and exercise capacity.
Copyright © 2025 Italian Federation of Cardiology - I.F.C. All rights reserved.
References
-
- Sutton R, Petersen MEV. The clinical spectrum of neurocardiogenic syncope. J Cardiovasc Electrophysiol 1995; 6:569–576.
-
- Salari N, Karimi Z, Hemmati M, Mohammadi A, Shohaimi S, Mohammadi M. Global prevalence of vasovagal syncope: a systematic review and meta-analysis. Glob Epidemiol 2024; 7:100136.
-
- Barón-Esquivias G, Gómez S, Aguilera A, et al. Short-term evolution of vasovagal syncope: influence on the quality of life. Int J Cardiol 2005; 102:315–319.
-
- Russo V, Tariq M, Parente E, et al. Prevalence and clinical predictors of vasodepressor syncope during head up tilt test. Eur J Intern Med 2024; 130:118–122.
-
- Russo V, Parente E, Comune A, et al. The clinical presentation of syncope influences the head-up tilt test responses. Eur J Intern Med 2023; 110:41–47.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources